You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Crispr Therapeutics primarily focuses on gene-editing products based on CRISPR/Cas9 technology. Its key product lines include hemoglobinopathies, immuno-oncology, regenerative medicine, and in vivo applications. |
Business Models for Each Product Line |
The revenue model is primarily based on collaborations and strategic partnerships, where the company engages in licensing agreements and receives milestone payments and royalties. Major expenses include research and development costs, clinical trial expenses, and operational costs related to scaling their technology. |
Future Opportunities for Growth |
Expansion into new therapeutic areas through CRISPR technology, successful progression of clinical trials for key pipeline products, and development of next-generation gene editing tools represent growth opportunities. Strategic partnerships with pharmaceutical companies can enhance product development and distribution. |
Potential Major Risks |
Major risks include regulatory hurdles for gene-edited therapeutics, potential competition from other gene-editing technologies, high R&D costs impacting financial stability, and uncertainties related to clinical trial outcomes. |
Learn More about Crispr Therapeutics:
Company Insights by Algobear (ChatGPT);
Tell me more about Crispr Therapeutics's latest earnings (CRSP:Nasdaq)
Who are some of Crispr Therapeutics's competitors? (CRSP:Nasdaq)
Are analysts bullish on Crispr Therapeutics? Please show it in a table format. (CRSP:Nasdaq)
Also read:
https://finance.yahoo.com/CRSP/profile
Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Trailing P/E | Forward P/E | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Return on Assets | Return on Equity | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Current Ratio | Operating Cash Flow-Display | Operating Cash Flow-Actual | Operating Cash Flow | Levered Free Cash Flow-Display | Levered Free Cash Flow-Actual | Levered Free Cash Flow | % Held by Insiders | % Held by Institutions |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.26 B | 3260000000.0 | 3.26 | 1.58 B | 1580000000.0 | 1.58 | 22.55 | 23.36 | 91.04 | 1.69 | 45.19 | 14.16 | 0.00% | -180.96% | -13.04% | -19.20% | 40.0 mn | 37310000.0 | 0.04 | -82.30% | -450.0 mn | -447310000.0 | -0.45 | -4.34 | 1.9 B | 1900000000.0 | 1.9 | 220.0 mn | 223690000.0 | 0.22 | 0.1158 | 22.07 | -140.0 mn | -142770000.0 | -0.14 | -30.0 mn | -29270000.0 | -0.03 | 1.65% | 84.17% |
source:https://finance.yahoo.com/CRSP/key-statistics
source:https://www.google.com/finance/quote/CRSP:NASDAQ
source:https://finance.yahoo.com/CRSP/analysis
source:https://finance.yahoo.com/CRSP/fair-value
source:https://www.nasdaq.com/market-activity/stocks/CRSP/price-earnings-peg-ratios
Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|
Upside % (high) | 29.96% | 5.76% (40.73) | 5.76% (40.73) | 45.11% (55.88) | 53.39% (59.0693) | 76.27% (67.88) | 136.56% (91.1) | 471.8% (220.2) |
Downside % (low) | 15.65% | 2.73% (37.46) | 21.99% (30.04) | 21.99% (30.04) | 21.99% (30.04) | 21.99% (30.04) | 21.99% (30.04) | 69.8% (11.63) |
Spread % | 14.31% | 3.04% | -16.23% | 23.11% | 31.39% | 54.27% | 114.57% | 402.0% |
CRSP's price used for computing the stats is 38.51 as on date
Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|---|
Last Price-Trend PrevClose | 1.66% | 1.82% | -2.01% | -1.71% | -12.87% | -19.85% | -30.8% | -30.65% | |
Last Price | 38.51 | 38.51 | 38.51 | 38.51 | 38.51 | 38.51 | 38.51 | 38.51 | 38.51 |
Trend-Previous Close | 37.88 | 37.82 | 39.3 | 39.18 | 44.2 | 48.05 | 55.65 | 55.53 | None |
CRSP's symbol cumulative return percent is computed basis data from date
5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5D window |
5D Opportunity:
returns:
1.82%
(5.05%),
p.close: 37.82
entry:
39.73,
exit:
39.16,
min.ret:
1.44%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.82%
(22.63%),
p.close: 37.82
entry:
46.38,
exit:
45.56,
min.ret:
1.77%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.82%
(17.59%),
p.close: 37.82
entry:
44.47,
exit:
44.48,
min.ret:
-0.02%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.82%
(18.1%),
p.close: 37.82
entry:
44.67,
exit:
44.08,
min.ret:
1.3%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.82%
(14.72%),
p.close: 37.82
entry:
43.39,
exit:
42.93,
min.ret:
1.05%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.82%
(12.32%),
p.close: 37.82
entry:
42.48,
exit:
42.15,
min.ret:
0.79%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2W window |
2W Opportunity:
returns:
-2.01%
(-8.39%),
p.close: 39.3
entry:
36.0,
exit:
40.4,
min.ret:
12.2%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-2.01%
(-24.59%),
p.close: 39.3
entry:
29.64,
exit:
28.6,
min.ret:
-3.5%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-2.01%
(-18.25%),
p.close: 39.3
entry:
32.13,
exit:
31.47,
min.ret:
-2.06%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-2.01%
(-16.94%),
p.close: 39.3
entry:
32.64,
exit:
32.32,
min.ret:
-0.98%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-2.01%
(-15.26%),
p.close: 39.3
entry:
33.3,
exit:
33.01,
min.ret:
-0.87%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1M window |
1M Opportunity:
returns:
-1.71%
(-29.8%),
p.close: 39.18
entry:
27.5,
exit:
28.51,
min.ret:
3.68%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-1.71%
(-27.21%),
p.close: 39.18
entry:
28.52,
exit:
29.91,
min.ret:
4.89%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-1.71%
(-24.68%),
p.close: 39.18
entry:
29.51,
exit:
30.43,
min.ret:
3.13%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-1.71%
(-22.57%),
p.close: 39.18
entry:
30.34,
exit:
31.07,
min.ret:
2.42%
Using: 1M trend, 0 Days Left
|
CRSP's symbol current price is 38.51 (1.66%) as on . Yesterday's close was 37.88. It's return velocities are computed basis data from date .
Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
Open-High (> 1.0%) | 74.48% | 80.0% | 68.18% | 75.76% | 69.7% | 66.67% | 69.44% |
Open-Low (> 1.0%) | 64.97% | 60.0% | 63.64% | 72.73% | 71.21% | 73.81% | 77.91% |
Open-Close-Up (> 0.5%) | 51.41% | 60.0% | 50.0% | 42.42% | 40.15% | 37.3% | 39.68% |
Open-Close-Down (> 0.5%) | 43.15% | 40.0% | 45.45% | 43.94% | 46.97% | 48.41% | 46.43% |
Low-Close-Up (> 1.0%) | 75.09% | 80.0% | 72.73% | 71.21% | 70.45% | 69.44% | 71.3% |
High-Close-Down (> 1.0%) | 91.13% | 100% | 86.36% | 87.88% | 77.27% | 75.79% | 75.53% |
CRSP's symbol win percent is computed basis data from date